Bristol Myers Squibb Discloses Expiration of RayzeBio Tender Offer; Company Gets Positive CHMP Opinion For Reblozyl (luspatercept) For Treatment of Adults With Transfusion-Dependent Anemia Due To Low-To-Intermediate-Risk Myelodysplastic Syndromes (MDS)

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!